Currently, auspicious results have been highlighted in a large variety of malignancies, but further research should confirm these findings and investigate intraoperative near-infrared imaging with pafolacianine in the remaining types of cancers that overexpress FRα. The gene discussed is FOLR1; the disease is cancer.